Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

Clicks: 223
ID: 110955
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #91 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We report the first data on within-person weight trajectories following switch to integrase inhibitor-based antiretroviral therapy while virologically suppresse
Reference Key
eclinicalrisk Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lake, Jordan E;for the ACTG A5322 Study Team;Wu, Kunling;for the ACTG A5322 Study Team;Bares, Sara H;for the ACTG A5322 Study Team;Debroy, Paula;for the ACTG A5322 Study Team;Godfrey, Catherine;for the ACTG A5322 Study Team;Koethe, John R;for the ACTG A5322 Study Team;McComsey, Grace A;for the ACTG A5322 Study Team;Palella, Frank J;for the ACTG A5322 Study Team;Tassiopoulos, Katherine;for the ACTG A5322 Study Team;Erlandson, Kristine M;for the ACTG A5322 Study Team;
Journal clinical infectious diseases
Year Year not found
DOI
DOI not found
URL
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa177/5758067?searchresult=1
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.